Skip to content

The effect of hesperidin in the treatment of diabetes

Effect of Supplementation of Hesperidin on Serum Glucose, Insulin, Insulin Resistance, Lipid Profile, Hemoglobin A1C, hs-CRP and IL6 in Type II Diabetic Mellitus Patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201407242602N12
Enrollment
48
Registered
2014-08-22
Start date
2014-09-10
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabet. Non-insulin-dependent diabetes mellitus

Interventions

Intervention 1: Hesperidin, Capsules 500 mg, 1 time a day for 2 months. Intervention 2: Starch placebo capsules, 500 mg, 1 time a day for 2 months.
Treatment - Drugs
Placebo
Hesperidin, Capsules 500 mg, 1 time a day for 2 months
Starch placebo capsules, 500 mg, 1 time a day for 2 months

Sponsors

Iran University Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Being volunteer or Wishing to attend 2.diagnosed with type 2 diabetes for at least 1 year (FPG = 126 mg/dl or 2hPG = 200 mg/dl)3. At least one year history of diabet 4. Not using tobacco 5. Lack of cardiovascular disease, liver disease, kidney disease, chronic inflammatory disease of the gastrointestinal tract 6.HbA1C < 8% 7. 20-65 y old 8. Lack of insulin 9. Not drinking alcohol 10. BMI<35 kg/m2 11. Not using any supplements, antioxidants and vitamins in the last 3 months 12. Not pregnant or nursing 13.TG<400 mg/dl 14. The absence of any skin allergies or digestive antioxidant supplements and vitamins. Exclusion criteria 1.The use of antioxidant supplements and vitamins 2.Use of insulin 3. See allergy symptoms at any time during the study 4.Taking over500ml beverages rich in flavonoids include tea, coffee, citrus juice, which it is determined by taking the 24-hour dietary recalls 5. Accept less than 70 6. Follow weight loss diets 7. NSAID nonsteroidal anti-inflammatory drugs and estrogens, oral contraceptives, anticonvulsants, corticosteroids

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
IL6. Timepoint: After the. Method of measurement: ELISA based on a scale pg / ml.;Hs CRP. Timepoint: After the intervention. Method of measurement: ELISA based on a scale ng / ml.;Glucose. Timepoint: Before the intervention and after the intervention. Method of measurement: Glucose oxidase method based on scale mg / dl.;Insulin. Timepoint: Before the intervention and after the intervention. Method of measurement: ELISA based on a scale µmol / ml.;Glycated hemoglobin. Timepoint: Before the intervention and after the intervention. Method of measurement: Chromatography based on the percentage of glycated hemoglobin.;TG. Timepoint: Before the intervention and after the intervention. Method of measurement: By an enzymatic method based on the scale mg / dl.;TC. Timepoint: Before the intervention and after the intervention. Method of measurement: By an enzymatic method based on the scale mg / dl.;LDL. Timepoint: Before the intervention and after the intervention. Method of measurement: To help Frydvald formula based on mg / dl.;HDL. Timepoint: Before the intervention and after the intervention. Method of measurement: By an enzymatic method based on the scale mg / dl.;Systolic blood pressure. Timepoint: Before the intervention and after the intervention. Method of measurement: Using a pressure gauge based on a scale mm Hg.;Diastolic blood pressure. Timepoint: Before the intervention and after the intervention. Method of measurement: Using a pressure gauge based on a scale mm Hg.;Insulin Resistance. Timepoint: Before the intervention and after the intervention. Method of measurement: Using the formula.

Secondary

MeasureTime frame
Age. Timepoint: Before the intervention and after the intervention. Method of measurement: Using Balance 0/1kg carefully based on kg scale.;BMI. Timepoint: Before the intervention and after the intervention. Method of measurement: Using the formula.;Physical activity. Timepoint: Before the intervention and after the intervention. Method of measurement: Using a questionnaire, based on three levels of light, medium and heavy.;Dietary intake. Timepoint: Before the intervention and after the intervention. Method of measurement: based on a 3-day recall measure kcal.;Gender. Timepoint: before the intervention. Method of measurement: Using view on men or women.;Types of drugs. Timepoint: Before the intervention and after the intervention. Method of measurement: Using a questionnaire based on observation.;Dose of drugs. Timepoint: Before the intervention and after the intervention. Method of measurement: Using a questionnaire based on the number of.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShahryar Eghtesadi

Iran University Medical School

egtesadi@iums.ac.ir, eghtesadi@yahoo.com+98 218670475

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026